| Species : |
Human |
| Source : |
Mammalian Cells |
| Tag : |
His |
| Protein Length : |
15-660 a.a. |
| Description : |
NLGN2 is one of severaltype I transmembrane Neuroligins that are expressed on neuronal postsynapticdensities. Neuroligins play an important role in synaptic development andfunction. Mature human NLGN2 is a 105 kDa protein that consists of a 663amino acid extracellular domain with a catalytically inactive cholinesterase-likedomain, a 21 aa transmembrane segment, and a 137 aa cytoplasmic tail. Withinthe ECD, human NLGN2 shares 98% aa sequence identity with mouse and ratNLGN2. |
| Form : |
Lyophilized from a0.2 μm filtered solution in PBS. |
| N-terminalSequence : |
Gln15 predicted |
| Molecular Weight : |
72 kDa |
| Activity : |
Measuredby its binding ability in a functional ELISA. When recombinant human NLGN2 is immobilized at 1.5 μg/mL, recombinant human Neurexin1β Fc Chimera binds with an apparent KD < 10 nM. |
| Endotoxin Level : |
<1.0 EUper 1 μg of the protein by the LAL method. |
| SDS-PAGE : |
85-95kDa, reducing conditions. |
| Purity : |
>95%,by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Reconstitution : |
400μg/mL in PBS |
| Storage : |
Use amanual defrost freezer and avoid repeated freeze-thaw cycles. 12 months fromdate of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterileconditions after reconstitution. 3 months, -20 to -70°C under sterile conditionsafter reconstitution. |